Zironi C, Pantaleoni M, Zizzo G, Coletta F, Velardo A
Cattedra di Endocrinologia, Università di Modena.
Minerva Ginecol. 1991 Oct;43(10):443-7.
To evaluate the hypothalamic dopaminergic activity in patients with polycystic ovary syndrome (PCOS), we studied the PRL, TSH, LH and FSH responses to i.m. administration of sulpiride in five euthyroid women affected by PCOS and in five normal women. The mean basal PRL and TSH plasma levels resulted significantly higher (p less than 0.01) in PCOS subjects with respect to normal subjects. The incremental area under PRL and TSH profiles, after sulpiride administration, were significantly lower (p less than 0.05) in PCOS patients than in the control group; no significant variation of LH and FSH plasma levels resulted. Our data suggest a decrease dopaminergic activity in PCOS.
为评估多囊卵巢综合征(PCOS)患者的下丘脑多巴胺能活性,我们研究了5名患PCOS的甲状腺功能正常女性及5名正常女性在肌肉注射舒必利后催乳素(PRL)、促甲状腺激素(TSH)、促黄体生成素(LH)和促卵泡生成素(FSH)的反应。PCOS患者的PRL和TSH基础血浆平均水平显著高于正常受试者(p<0.01)。注射舒必利后,PCOS患者PRL和TSH曲线下的增量面积显著低于对照组(p<0.05);LH和FSH血浆水平无显著变化。我们的数据表明PCOS患者多巴胺能活性降低。